Pharmacological treatment reduces specific crimes in adolescents with ADHD

Eliem Ther­a­peu­tics has un­der­gone a strate­gic re­view just two years af­ter launch­ing dur­ing the pan­dem­ic biotech boom. Eliem said Thurs­day morn­ing it plans to ex­plore

Neu­ro­crine Bio­sciences said its treat­ment for con­gen­i­tal adren­al hy­per­pla­sia (CAH) — a ge­net­ic dis­or­der that caus­es hor­mone im­bal­ance  — helped re­duce the dai­ly dose of